Articles
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Eko Health announced that clinicians in the UK can now purchase the company's CORE 500 digital stethoscope, Eko+ membership and accessories via the company's website and Amazon UK. Eko helps healthcare professionals identify and monitor heart and lung disease with digital stethoscopes, patient and provider software, and AI-enabled analysis.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Data from the J.D. Power 2025 U.S. Healthcare Digital Experience Study revealed that health insurance members enrolled in health plans and Medicare Advantage plans use their plan websites and mobile apps as their primary means of communication, but the quality of these digital experiences lags behind that of other industries. In the study, Cigna Healthcare ranked highest in satisfaction among commercial member health plans, Kaiser Foundation Health Plan ranked second and Centene ranked third.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Specialty pharmaceutical distributor Morris & Dickson is partnering with Mark Cuban's Cost Plus Drug Company (MCCPDC) and the Cost Plus Marketplace to ensure access to vital injectable medications. MCCPDC offers consumers a broad range of low-cost prescription and over-the-counter drugs from National Association of Boards of Pharmacy (NABP) accredited suppliers.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines. The de novo classification is for the company’s CT-132 offering, which it received FDA Breakthrough Device Designation for in 2022. CT-132 is intended for the preventive treatment of episodic migraine in patients 18 years of age and older. It is meant for adjunctive use along with acute and/or other preventive treatments.
-
1 week ago |
mobihealthnews.com | Anthony Vecchione
Reimagine Care announced it is joining forces with healthcare system MedStar Health to integrate its on-demand oncology care platform into the health system's cancer care delivery model and assist patients with the transition from in-clinic care to the home. Reimagine Care's patient-centered model provides patients with customized all-inclusive care from their homes using technology, data insights and a multidisciplinary care team.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 35
- Tweets
- 101
- DMs Open
- No
Jersey angst |A new survey reveals that 30 percent of New Jerseyans are very concerned about losing their jobs as a result of the COVID-19 outbreak. Read about how Garden State residents are being impacted by the pandemic. https://t.co/OtATDgW2yv
Jersey influence | Catalent Inc. @CatalentPharma is collaborating with Janssen Pharmaceutical Cos. to accelerate the availability of manufacturing capacity, and prepare for large-scale commercial manufacturing for J&J lead vaccine candidate for COVID-19. https://t.co/oK6TlxlkuS
Expanded testing | There has been a lot of pressure to increase COVID-19 testing. CVS expanded its testing capabilities and will offer self-swab tests at their Minute Clinics in New Jersey. https://t.co/pKkFZs2vH5